Complete Filing Data
SOPHiA GENETICS SA reported Cash And Cash Equivalents of $70.29 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SOPHiA GENETICS SA did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Sales And Marketing Expense | $36.1M | $29.4M | $28.4M | $28.3M | $28.7M | $17.4M | $19.4M |
| Revenue From Contracts With Customers | $77.3M | $65.2M | $62.4M | $47.6M | $40.5M | $28.4M | $25.4M |
| Research And Development Expense | $34.2M | $34.4M | $37.0M | $35.4M | $26.6M | $18.6M | $15.0M |
| Profit Loss Before Tax | -$77.5M | -$61.3M | -$78.5M | -$87.6M | -$73.5M | -$41.2M | -$33.6M |
| Profit Loss Attributable To Owners Of Parent | -$79.0M | -$62.5M | -$79.0M | -$87.4M | -$73.7M | -$39.3M | -$33.8M |
| Profit Loss | -$79.0M | -$62.5M | -$79.0M | -$87.4M | -$73.7M | -$39.3M | -$33.8M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | $704.0K | $327.0K | -$212.0K | $2.2M | $461.0K | $184.0K | -$1.5M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | $11.3M | -$9.7M | $15.0M | -$4.3M | -$4.7M | $7.3M | $272.0K |
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $704.0K | $327.0K | -$212.0K | $2.2M | $461.0K | $184.0K | -$1.5M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $11.3M | -$9.7M | $15.0M | -$4.3M | -$4.7M | $7.3M | $272.0K |
| Other Comprehensive Income | $12.0M | -$9.4M | $14.8M | -$2.2M | -$4.3M | $7.5M | -$1.3M |
| Income Tax Expense Continuing Operations | $1.5M | $1.2M | $486.0K | -$136.0K | $168.0K | -$1.9M | $162.0K |
| Gross Profit | $52.1M | $43.9M | $42.9M | $31.3M | $25.2M | $17.7M | $17.8M |
| General And Administrative Expense | $52.6M | $47.0M | $53.3M | $55.8M | $41.5M | $19.0M | $15.7M |
| Cost Of Sales | $25.2M | $21.2M | $19.5M | $16.3M | $15.2M | $10.7M | $7.5M |
| Comprehensive Income Attributable To Owners Of Parent | -$67.0M | -$71.8M | -$64.2M | -$89.6M | -$78.0M | -$31.8M | -$35.0M |
| Comprehensive Income | -$67.0M | -$71.8M | -$64.2M | -$89.6M | -$78.0M | -$31.8M | -$35.0M |
| Profit Loss From Operating Activities | -$70.9M | -$66.6M | -$74.8M | -$87.8M | -$71.5M | -$37.4M | |
| Income Taxes Paid Refund Classified As Operating Activities | $200.0K | $536.0K | $801.0K | $0.00 | $55.0K | -$153.0K | $252.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $70.3M | $80.2M | $123.3M | $161.3M | $193.0M | $74.6M | $18.1M | $53.9M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $574.0K | $244.0K | $1.5M | $4.1M | $2.7M | $450.0K | $1.4M | |
| Purchase Of Intangible Assets Classified As Investing Activities | $108.0K | $195.0K | $263.0K | $464.0K | $130.0K | $318.0K | $1.7M | |
| Cash Flows From Used In Operating Activities | -$35.9M | -$44.5M | -$53.2M | -$70.1M | -$57.9M | -$31.7M | -$31.7M | |
| Cash Flows From Used In Investing Activities | -$8.7M | -$4.8M | $13.0M | $42.0M | -$56.9M | -$24.3M | -$3.0M | |
| Cash Flows From Used In Financing Activities | $30.2M | $9.9M | -$2.8M | -$1.6M | $237.8M | $107.0M | -$1.0M | |
| Adjustments For Increase Decrease In Trade And Other Payables | $16.9M | -$7.4M | $6.9M | -$1.4M | $9.0M | -$185.0K | $5.6M | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | $649.0K | $1.6M | $308.0K | $953.0K | -$23.0K | $1.2M | $580.0K | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$6.6M | $5.9M | -$6.5M | $1.3M | $1.8M | $1.1M | -$4.4M | |
| Rightofuse Assets | $12.4M | $14.2M | $15.6M | $14.3M | $11.3M | $3.8M | $4.5M | |
| Trade And Other Current Receivables | $15.0M | $7.4M | $13.6M | $6.6M | $6.3M | $6.4M | ||
| Trade And Other Current Payables To Trade Suppliers | $9.0M | $5.2M | $5.4M | $6.2M | $6.7M | $5.9M | ||
| Retained Earnings | -$519.3M | -$440.3M | -$377.8M | -$298.8M | -$211.4M | -$137.7M | ||
| Property Plant And Equipment | $5.7M | $5.2M | $7.5M | $7.1M | $4.7M | $1.8M | ||
| Other Noncurrent Liabilities | $876.0K | $337.0K | $334.0K | $170.0K | $471.0K | $1.4M | ||
| Other Noncurrent Assets | $8.2M | $5.8M | $6.1M | $4.3M | $3.7M | $1.5M | ||
| Noncurrent Liabilities | $65.4M | $32.0M | $19.1M | $16.9M | $16.2M | $10.0M | ||
| Noncurrent Lease Liabilities | $12.6M | $14.6M | $15.7M | $14.1M | $11.2M | $2.9M | ||
| Noncurrent Assets | $64.0M | $55.9M | $58.1M | $47.6M | $37.3M | $22.4M | ||
| Net Deferred Tax Assets | $1.8M | $1.8M | $1.7M | $1.9M | $2.0M | $2.1M | ||
| Liabilities | $115.9M | $58.8M | $54.7M | $43.7M | $44.8M | $31.6M | ||
| Intangible Assets Other Than Goodwill | $35.9M | $29.0M | $27.2M | $20.0M | $15.7M | $13.3M | ||
| Equity And Liabilities | $163.0M | $155.3M | $206.2M | $243.8M | $320.2M | $132.1M | ||
| Current Prepayments And Other Current Assets | $7.4M | $5.9M | $4.8M | $5.8M | $5.5M | $2.6M | ||
| Current Liabilities | $50.5M | $26.8M | $35.6M | $26.8M | $28.6M | $21.6M | ||
| Current Lease Liabilities | $2.7M | $2.2M | $2.9M | $2.7M | $1.8M | $1.0M | ||
| Current Deferred Income Including Current Contract Liabilities | $16.7M | $5.7M | $9.5M | $3.4M | $4.1M | $2.6M | ||
| Current Assets | $99.1M | $99.4M | $148.0M | $196.3M | $282.9M | $109.7M | ||
| Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments | $0.00 | $0.00 | $17.5M | $78.5M | $21.9M | $0.00 | ||
| Assets | $163.0M | $155.3M | $206.2M | $243.8M | $320.2M | $132.1M | ||
| Noncurrent Recognised Liabilities Defined Benefit Plan | $4.2M | $3.8M | $3.1M | $2.7M | $4.5M | |||
| Current Accrued Expenses | $20.7M | $13.2M | $17.8M | $14.5M | $16.0M | |||
| Adjustments For Fair Value Of Warrant Liability | -$497.0K | $370.0K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Proceeds From Exercise Of Options | $346.0K | $405.0K | $226.0K | $748.0K | $4.5M | $1.1M | $1.8M |
| Payments Of Lease Liabilities Classified As Financing Activities | $1.9M | $2.8M | $3.0M | $2.3M | $918.0K | $980.0K | $816.0K |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$14.4M | -$39.4M | -$43.1M | -$29.7M | $122.9M | $51.0M | -$35.7M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $4.4M | -$3.6M | $5.0M | -$2.0M | -$4.6M | $5.6M | -$102.0K |
| Proceeds From Borrowings Classified As Financing Activities | $34.6M | $13.9M | $0.00 | $0.00 | $0.00 | $15.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-1.17 | $-0.95 | $-1.22 | $-1.36 | $-1.33 | $-0.93 |
| Basic Earnings Loss Per Share | $-1.17 | $-0.95 | $-1.22 | $-1.36 | $-1.33 | $-0.93 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Other Operating Income Expense | -$86.0K | $183.0K | $954.0K | $377.0K | $108.0K | -$93.0K | -$16.0K |
| Increase Decrease Through Sharebased Payment Transactions | $16.2M | $16.5M | $15.2M | $13.6M | $8.5M | $1.4M | $717.0K |
| Increase Decrease Through Exercise Of Options | $4.5M | $1.1M | $1.8M | ||||
| Amortisation Expense | $5.6M | $4.0M | $2.8M | $1.8M | $1.1M | $632.0K | $367.0K |
| Adjustments For Sharebased Payments | $16.2M | $16.5M | $15.2M | $13.6M | $8.5M | $1.4M | $717.0K |
| Adjustments For Research Tax Credit | $977.0K | $726.0K | $1.1M | $1.3M | $1.6M | $763.0K | $447.0K |
| Adjustments For Depreciation Expense | $4.0M | $4.6M | $5.5M | $3.8M | $2.5M | $1.8M | $1.5M |
| Adjustments For Decrease Increase In Prepaid Expenses | $334.0K | -$1.2M | $1.4M | -$977.0K | -$2.3M | $2.3M | -$2.0M |
| Adjustments For Decrease Increase In Inventories | $46.0K | $69.0K | -$874.0K | -$200.0K | -$2.3M | $536.0K | -$862.0K |
| Adjustments For Credit Loss Allowance | $57.0K | -$523.0K | $214.0K | -$467.0K | -$988.0K | $763.0K | $872.0K |
| Capitalized Software Development Costs | $7.9M | $7.7M | $7.5M | $5.8M | $3.9M | $2.4M | |
| Share Premium | $473.7M | $472.2M | $471.8M | $471.6M | $470.9M | $227.4M | |
| Other Reserves | $89.2M | $61.0M | $54.0M | $24.0M | $12.5M | $8.3M | |
| Issued Capital | $4.8M | $4.2M | $4.0M | $3.5M | $3.3M | $2.5M | |
| Inventories | $6.4M | $5.9M | $6.5M | $5.2M | $5.7M | $3.4M | |
| Foreign Exchange And Other Gain Loss | -$3.4M | $3.5M | -$7.6M | -$447.0K | -$1.4M | ||
| Interest Received Classified As Operating Activities | $4.7M | $1.3M | $14.0K | $75.0K | $36.0K | ||
| Interest Paid Classified As Operating Activities | $6.0K | $266.0K | $286.0K | $855.0K | $837.0K | ||
| Treasury Shares | 1.2M | 702.0K | 646.0K | 117.0K | 0.00 |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.